文献速递关节外科

金属对金属全髋关节承重面血清钴铬安全上限:10年随访研究

Safe Upper Limits of Serum Cobalt and Chromium Levels for a Metal-on-Metal Total Hip Bearing: A 10-Year Follow-Up Study.
PubMed 文献 · J Arthroplasty · 2021-01-23

结果显示女性、髋臼杯倾斜角超过45°及末次钴铬水平较高与ARMD翻修风险升高相关,并确定该承重面钴和铬的安全上限分别为4.1 ppb和4.2 ppb。

要点

  • 女性ARMD翻修风险升高(sdHR 3.43)。
  • 髋臼杯倾斜角超过45°翻修风险升高(sdHR 4.70)。
  • 该承重面钴、铬安全上限分别为4.1和4.2 ppb。

核心结论

  • 对于M2a-Magnum金属对金属承重面,建议血清钴和铬的安全上限分别为4.1 ppb和4.2 ppb。
  • 随访和监测指南应包含结合承重面特异性血清金属离子安全上限的完整临床评估。

研究设计与样本

  • 采用累积发生率函数估计翻修风险,并用亚分布风险模型分析ARMD翻修与钴铬水平、性别、年龄、头尺寸和髋臼杯倾斜角的关联。

主要发现

  • 女性ARMD翻修风险升高(sdHR 3.43,95%CI 1.01-11.7,P=.049)。
  • 髋臼杯倾斜角超过45°者ARMD翻修风险升高(sdHR 4.70,95%CI 1.63-13.58,P=.004)。
  • 末次测量的钴水平较高与ARMD翻修概率升高相关(sdHR 1.05,95%CI 1.03-1.07,P<.001)。
  • 末次测量的铬水平较高与ARMD翻修概率升高相关(sdHR 1.21,95%CI 1.14-1.29,P<.001)。

关键数值与推荐

  • 该承重面特异性血清钴安全上限为4.1 ppb。
  • 该承重面特异性血清铬安全上限为4.2 ppb。

临床怎么用

  • 对使用M2a-Magnum金属对金属承重面的患者,随访时应结合承重面特异性血清钴铬安全上限进行完整临床评估。
  • 对女性及髋臼杯倾斜角超过45°的患者,应关注ARMD翻修风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term survival of metal-on-metal (MoM) prostheses and the development of adverse reaction to metal debris (ARMD) around these bearings are still unclear. Serum levels of cobalt (Co) and chromium (Cr) are used as a screening tool to anticipate failure in MoM bearings and detect ARMD. METHODS: One hundred sixty primary large head MoM prostheses were followed up for 10 years. To estimate the revision risk, the cumulative incidence function (CIF) was used. Subdistribution hazard modeling was used to investigate the associations between cumulative incidence of revision for ARMD and Co levels, Cr levels, gender, age, head size, and cup inclination. Furthermore, the safe upper limits (SULs) for Co and Cr were determined. RESULTS: Univariate analyses showed an increased risk in revision for ARMD in females (subdistribution hazard ratio [sdHR] 3.43, 95% confidence interval [CI] 1.01-11.7, P = .049) and cup inclination angles over 45° (sdHR 4.70, 95% CI 1.63-13.58, P = .004). In addition, a higher last measured Co level (sdHR 1.05, 95% CI 1.03-1.07, P < .001) and last measured Cr level (sdHR 1.21, 95% CI 1.14-1.29, P < .001) were associated with a higher probability of revision for ARMD. We determined our bearing-specific SULs at 4.1 parts per billion (ppb) and 4.2 ppb for Co and Cr, respectively. CONCLUSION: Guidelines regarding follow-up and surveillance should include a complete clinical assessment with bearing-specific SULs of serum metal ion levels. For the M2a-Magnum MoM bearing we advise an SUL for Co and Cr levels of 4.1 and 4.2 ppb, respectively.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Koper MC, Hesseling B, Tuinebreijer WE, et al. Safe Upper Limits of Serum Cobalt and Chromium Levels for a Metal-on-Metal Total Hip Bearing: A 10-Year Follow-Up Study. J Arthroplasty. 2021. PMID: 33612330. doi:10.1016/j.arth.2021.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。